In vivo assays also confirmed that BrM-CSCs have a stronger ability to induce angiogenesis compared with PC9-CSCs (Figure 1C and S1G), and the progressive densification of intra-tumoral blood vessels, in parallel with the rapid tumor growth, was observed in BrM-CSC-bearing mice (Figure 1D). The gene discussed is SMARCA2; the disease is neoplasm.